数字乳腺断层合成与数字乳腺X线摄影筛查的资源利用与临床结局比较:来自学习型健康系统的发现
该研究分析了两个医疗系统内247,431名女性的325,729次筛查乳腺摄影,比较单独数字乳腺X线摄影(DM)与联合数字乳腺断层合成(DBT)的结局。DBT总体召回率更低(8.83% vs 10.98%,调整OR 0.85,95%CI 0.83-0.87),且在各年龄、种族和乳腺密度亚组中均更低;DBT的调整癌症率、癌症检出率和特异度更高,活检和最终诊断的中位时间更短。
要点
- DBT筛查总体召回率低于DM(8.83% vs 10.98%,调整OR 0.85,95%CI 0.83-0.87),各年龄、种族和乳腺密度亚组均一致。
- DBT的调整癌症率、癌症检出率和特异度均高于DM。
- DBT召回后直接进行超声的比例更高,活检中位时间(18 vs 22天)和最终诊断中位时间(10 vs 13天)更短。
核心结论
- DBT展示了更高效的筛查路径,在所有患者类型中降低了召回率,减少了诊断性乳腺X线摄影,并缩短了活检和最终诊断时间,改善了质量指标。
研究设计与样本
- 回顾性分析两个医疗系统2015年6月至2017年9月的325,729次筛查乳腺摄影(来自247,431名女性),数据提取自放射信息系统和电子病历,采用多变量回归模型调整机构、年龄、乳腺密度和首次检查。
诊断标准与关键数值
- DBT组筛查194,437次(59.7%),DM组131,292次(40.3%);总体召回率DBT 8.83% vs DM 10.98%,调整OR 0.85(95%CI 0.83-0.87);以DBT为主的机构召回率8.05%,以DM为主的机构11.22%,联合使用机构10.73%。
临床应用与阅片要点
- 原文报告DBT召回后更常直接进行超声,且活检和最终诊断时间更短;原文未给出基于上述结果的具体阅片或报告建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To compare outcomes associated with breast cancer screening with digital mammography (DM) alone versus in combination with digital breast tomosynthesis (DBT) in a large representative cohort.
MATERIALS AND METHODS: A total of 325,729 screening mammograms from 247,431 women were analyzed, across two healthcare systems, from June 2015 to September 2017. Patient level demographic, calculated risk levels, and clinical outcomes were extracted from radiology information system and electronic medical records. Multivariable regression modeling adjusting for institution, age, breast density, and first exam was conducted to compare patient characteristics, recall rates, time to biopsy and final diagnosis, clinical outcomes, and diagnostic performance. Participating institutions and the Coordinating Center received Institutional Review Board approval for a waiver of consent to collect and link data and perform analysis.
RESULTS: A total of 194,437 (59.7%) screens were DBT versus 131,292 (40.3%) with DM. Women with dense breasts and higher calculated risk were more likely to be screened with DBT. Recall rates were lower for DBT overall (8.83% DBT vs 10.98% DM, adjusted odds ratio, 95% confidence interval = 0.85, 0.83-0.87) and across all age groups, races, and breast densities, and at facilities that used predominantly DBT (8.05%) versus predominantly DM (11.22%), or a combination (10.73%). The most common diagnostic pathway after recall was mammography and ultrasound. Women recalled from DBT were more likely to proceed directly to ultrasound. The median time to biopsy (18 vs 22 days) and final diagnosis (10 vs 13 days) was shorter for DBT. The adjusted cancer rate, cancer detection rate, and specificity were higher for DBT.
CONCLUSION: DBT demonstrated a more efficient screening pathway and improved quality measures with lower recall rates in all patient types, reduced diagnostic mammography and shorter time to biopsy and final diagnosis.
引用
- Alsheik NH, Dabbous F, Pohlman SK, et al. Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System. Acad Radiol. 2018. PMID: 30057195. doi:10.1016/j.acra.2018.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。